MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202617070968 A) filed by Rigshospitalet; and University Of Copenhagen on June 08, 2026, for Antibodies And Molecular Conjugates Thereof Targeting Upar.
Inventors include Engelholm, Lars Henning; Metrangolo, Virginia; and Ploug, Michael.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: The present invention relates to antibodies and molecular conjugates targeting the receptor uPAR, in particular antibody-drug conjugates (ADCs) of said antibodies and their use in delivery of active agents to cells and tissues expressing uPAR. The invention further relates to the use of said ADCs in the treatment of diseases involving uPAR expressing cells, such as certain cancers.
Disclaimer: Curated by HT Syndication.
